From what I’ve heard and been able to gather, Alan is
From what I’ve heard and been able to gather, Alan is working on closing a financial deal that will give us the money we need right now to push a few things further along through FDA trials.
This (my guess is around $8M) financial deal would obviously come at a perfect time to get us over the hump and allow us to have an FDA approved device assuming it all goes well (and it should), but it also opens us up to be able to sell the device on the open market, go JV with somebody, straight up sell the entire device to a big pharma company. That last option would give us the money we need to run every other parent we have through FDA trials, or close to it.
But my point is, even though we won’t get a perfect financial deal (it’ll cost us shares and/or a good chunk of interest down the road....we ARE in the OTC still afterall), it will give us the ability to take that next step and we need it.
So right now it’s being worked on, terms being negotiated and might be checking multiple sources to see who’s willing to give us the best terms. Takes time to do.
But that should probably be the next big announcement we get. And imo it’s a big one! We need money and this can move our piece into the final puzzle spot so that we can start collecting revenue or a straight up lump sum if we just sell outright.
This is all in my opinion.
2
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sivers Semiconductors Announces Partnership with DigiKey In an exciting development for the tech industry, Sivers Semiconductors AB (STO:SIVE), known for its expertise in photonics and wireless technologies, has formed a strategic partnership with DigiKey. This collaboration is designed to enhance the accessibility of Sivers' cutting-edge millimeter-wave products and...
Continue Reading
Transformative Partnership in Personal Injury Law LawPro.ai, an innovative AI-powered case intelligence platform designed to enhance case preparation, has joined forces with SmartAdvocate, a renowned case management system favored by legal professionals countrywide. This collaboration aims to revolutionize the workflow in personal injury law, enabling firms to prepare...
Continue Reading
Transforming the UK Tyre Industry Tyres.co.uk is gearing up to shake up the UK's extensive and lucrative tyre market. With an advanced technological platform and a prime domain name, this startup aims to streamline the tyre buying and fitting process for motorists across the nation. As the launch date approaches, anticipation grows for how this service will enhance the...
Continue Reading
Exploring Body Image in Today's Society In a world where social media and advertising continually influence our perceptions of beauty, Adam & Eve has remained a beacon of body positivity and self-acceptance. This renowned company conducted a revealing survey among over 1,000 adults, asking an intriguing question: "What’s the one thing you would change about your body if...
Continue Reading
Eyes on the Earnings: What to Expect from ESTA Okay, let's cut to the chase. February 24, 2026—a date that's gonna hit the calendar hard for investors in Establishment Labs Hldgs (NASDAQ:ESTA). They're gearing up to toss out their quarterly earnings, and honestly, folks have their fingers crossed. Analysts point to an expected earnings per share (EPS) of $-0.22. Not...
Continue Reading